Aristeia Capital’s Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share CCV.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-168,242
Closed -$104K 727
2022
Q1
$104K Hold
168,242
﹤0.01% 546
2021
Q4
$165K Hold
168,242
﹤0.01% 550
2021
Q3
$216K Hold
168,242
﹤0.01% 464
2021
Q2
$347K Hold
168,242
0.01% 418
2021
Q1
$217K Buy
+168,242
New +$419K ﹤0.01% 426

Other funds holding CCV.WS

Aristeia Capital's CCV.WS Position: Q2 2022 in Review

Aristeia Capital sold out of Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share (CCV.WS) in Q2 2022, closing a stake of 168,242 shares — an estimated $104K sold.

Aristeia Capital first reported a position in CCV.WS in Q1 2021 and held it in 5 quarters. The position peaked at $347K in Q2 2021. 35 funds tracked by Wall St. Rank hold CCV.WS as of Q2 2022.

  • Aristeia Capital reported no remaining Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q2 2022 after selling out during the quarter.
  • Aristeia Capital sold 168,242 Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q2 2022, an estimated $104K.
  • Aristeia Capital first reported a position in Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q1 2021 and held it in 5 quarters.
  • Aristeia Capital's Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $347K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q2 2022.

Based on Aristeia Capital's 13F filing for Q2 2022, filed 16 Aug 2022.